FRONTIER · GLOBAL
AI-designed coronavirus vaccine clears first human trial
A vaccine designed by AI algorithms has passed Phase 1 human safety trials, marking the first regulatory milestone for an AI-discovered therapeutic candidate.
WHY IT MATTERS
Proof-of-concept for AI-augmented drug discovery. BFSI relevance: biotech/pharma funding and insurance models shift as AI accelerates time-to-market; reduces R&D cost assumptions.
Source: iNews Zoombangla · 2026-06-22